1. Home
  2. PSTV vs FSEA Comparison

PSTV vs FSEA Comparison

Compare PSTV & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • FSEA
  • Stock Information
  • Founded
  • PSTV 1996
  • FSEA 1890
  • Country
  • PSTV United States
  • FSEA United States
  • Employees
  • PSTV N/A
  • FSEA N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • FSEA Savings Institutions
  • Sector
  • PSTV Health Care
  • FSEA Finance
  • Exchange
  • PSTV Nasdaq
  • FSEA Nasdaq
  • Market Cap
  • PSTV 61.1M
  • FSEA 54.1M
  • IPO Year
  • PSTV N/A
  • FSEA N/A
  • Fundamental
  • Price
  • PSTV $0.51
  • FSEA $11.63
  • Analyst Decision
  • PSTV Strong Buy
  • FSEA
  • Analyst Count
  • PSTV 4
  • FSEA 0
  • Target Price
  • PSTV $7.75
  • FSEA N/A
  • AVG Volume (30 Days)
  • PSTV 9.7M
  • FSEA 2.8K
  • Earning Date
  • PSTV 10-30-2025
  • FSEA 11-07-2025
  • Dividend Yield
  • PSTV N/A
  • FSEA N/A
  • EPS Growth
  • PSTV N/A
  • FSEA N/A
  • EPS
  • PSTV N/A
  • FSEA N/A
  • Revenue
  • PSTV $5,258,000.00
  • FSEA $14,095,000.00
  • Revenue This Year
  • PSTV $9.91
  • FSEA N/A
  • Revenue Next Year
  • PSTV $1.06
  • FSEA N/A
  • P/E Ratio
  • PSTV N/A
  • FSEA N/A
  • Revenue Growth
  • PSTV N/A
  • FSEA 30.26
  • 52 Week Low
  • PSTV $0.16
  • FSEA $9.00
  • 52 Week High
  • PSTV $2.31
  • FSEA $11.95
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 40.47
  • FSEA 55.84
  • Support Level
  • PSTV $0.49
  • FSEA $11.53
  • Resistance Level
  • PSTV $0.55
  • FSEA $11.70
  • Average True Range (ATR)
  • PSTV 0.05
  • FSEA 0.05
  • MACD
  • PSTV -0.02
  • FSEA 0.01
  • Stochastic Oscillator
  • PSTV 10.97
  • FSEA 71.43

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.

Share on Social Networks: